Header Logo

Connection

George Hofmeyr to Medroxyprogesterone Acetate

This is a "connection" page, showing publications George Hofmeyr has written about Medroxyprogesterone Acetate.
Connection Strength

4,327
  1. Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trial. PLoS One. 2024; 19(5):e0299802.
    View in: PubMed
    Score: 0,906
  2. Effects of three contraceptive methods on depression and sexual function: An ancillary study of the ECHO randomized trial. Int J Gynaecol Obstet. 2021 Aug; 154(2):256-262.
    View in: PubMed
    Score: 0,726
  3. Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk. Lancet HIV. 2015 Sep; 2(9):e365.
    View in: PubMed
    Score: 0,496
  4. Hypothesis: amenorrhea-inducing contraception may reduce HIV acquisition risk. Contraception. 2014 Dec; 90(6):615-6.
    View in: PubMed
    Score: 0,464
  5. Copper containing intra-uterine devices versus depot progestogens for contraception. Cochrane Database Syst Rev. 2010 Jun 16; (6):CD007043.
    View in: PubMed
    Score: 0,346
  6. The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial. PLoS One. 2024; 19(8):e0307736.
    View in: PubMed
    Score: 0,231
  7. Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial. PLoS One. 2024; 19(3):e0295764.
    View in: PubMed
    Score: 0,225
  8. Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial. BMC Womens Health. 2024 Mar 08; 24(1):167.
    View in: PubMed
    Score: 0,224
  9. Misreporting contraceptive use and the association of peak study progestin levels with weight and BMI among women randomized to the progestin-only injectable contraceptives DMPA-IM and NET-EN. PLoS One. 2023; 18(12):e0295959.
    View in: PubMed
    Score: 0,221
  10. Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease Progression. AIDS Res Hum Retroviruses. 2020 08; 36(8):632-640.
    View in: PubMed
    Score: 0,172
  11. Changes to the World Health Organization guideline on hormonal contraceptive eligibility for women at high risk of HIV: South African perspective and response. S Afr Med J. 2018 Jul 25; 108(8):629-631.
    View in: PubMed
    Score: 0,152
  12. Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial. Reprod Health. 2016 Apr 18; 13:42.
    View in: PubMed
    Score: 0,130
  13. Psychological, behavioural and physiological effects of three long-acting reversible contraception (LARC) methods: protocol for an ancillary study of the ECHO randomised trial. BMJ Open. 2017 Nov 12; 7(11):e019205.
    View in: PubMed
    Score: 0,036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.